Simple Summary In this review, we present current knowledge of sex hormones in the
process of development of malignant diseases. The impact of sex hormones on immune …

Since its emergence, the application of CRISPR-associated nuclease 9 (Cas9) technology
in cancer research has accelerated studies to investigate many aspects of treatment …

Lung cancer, the second most commonly diagnosed cancer, is the major cause of fatalities
worldwide for both men and women, with an estimated 2.2 million new incidences and 1.8 …

Background A hormonal role in the development of non-small cell lung cancer (NSCLC) has
been well documented, and the classic estrogen receptors (ERs)—ERα and ERβ have been …

Simple Summary Non-small cell lung cancer (NSCLC) is the most common type of lung
cancer. Smoking is a major risk factor for NSCLC; however, the incidence of NSCLC among …

Background An increasing number of original studies suggest that estrogen receptor beta
(ERβ) expression may be related to non-small cell lung cancer (NSCLC) prognosis; …

Proline, glutamate, and leucine-rich protein 1 (PELP1) are involved in several cancers, but
little is known about PELP1 in lung cancer. In this study, PELP1 expression was evaluated in …

Signet ring cell gastric carcinoma (SRCGC) is a poorly differentiated malignancy, and can
be highly dangerous in the progression stage. There is a higher male to female ratio among …

Epidermal growth factor receptor inhibitors (EGFRi) have exhibited promising clinical
outcomes in the treatment of various cancers. However, their widespread application has …

Exosomes, released from various cell types, serve as vehicles of intercellular
communication. Rearranged anaplastic lymphoma kinase (ALK) has been detected in …